Living a healthy life means knowing the symptoms of chlamydia and taking the necessary precautions under a doctor's guidance.

The FDA has granted Fast Track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection.

The U.S. Food and Drug Administration granted marketing authorization for the first home-based, nonprescription diagnostic ...

Jean-François Toussaint, Sanofi's global head of vaccines R&D, speaking at a conference at the company's site in Lyon last ...

Visby Medical’s at-home diagnostic, which can be purchased without a prescription, tests for chlamydia, gonorrhea and trichomoniasis.

Caused by the bacterium Chlamydia trachomatis, chlamydia is a common bacterial infection of the reproductive tract that can lead to infertility and pregnancy complications. The vaccine candidate ...

Chlamydia vaccine candidate granted fast track designation by the US FDAChlamydia infection can contribute to pelvic inflammatory diseases in ...

Paris: Sanofi has received the US Food and Drug Administration (USFDA) fast-track designation for its mRNA vaccine candidate ...

The US Food and Drug Administration has approved a single-use at-home test which can detect three STIs in women. Read on to ...

Sanofi’s chlamydia vaccine candidate was designed to protect against primary genital tract infection and reinfection by the bacterium Chlamydia trachomatis. The Food and Drug Administration (FDA ...

Chlamydia infection can contribute to pelvic inflammatory diseases in women, which can lead to pregnancy complications or infertility A phase 1/2 clinical study evaluating the immunogenicity and ...

The US Food and Drug Administration (FDA) has granted marketing authorization for the first at-home test to diagnose ...